In this episode of Med Tech Talks, Robert Klupacs (CEO of the Bionics Institute) chats with Dr Ludovic Labat (CEO of Neo-Bionica) about how Australia should approach the global med tech market to increase our innovation output.

Dr Labat is the inaugural CEO of Neo-Bionica, an initiative of the Bionics Institute and the University of Melbourne.

Neo-Bionica is the first company of its kind in Australia, with the bioengineering expertise, specialised fabrication skills and regulatory experience required to create first-in-human prototypes for clinical trials.

Specialising in neuromonitoring and neuromodulation technologies, Neo-Bionica aims to position Australia as leaders in medical device prototype and manufacturing.

In this episode you will hear about:

Ludovic's journey to becoming CEO of the highly innovative start-up Neo-Bionica
Neo-Bionica’s mission, and how its team can accelerate the journey to market for medical devices
How Australia can better understand global markets to increase commercialisation success of our innovations.

More information:

Learn more about Neo-Bionica: Neo-Bionica

Find out more about Dr Ludovic Labat and his team at Neo-Bionica

Updated version 05/08/22

Understanding global med tech markets with Neo-Bionica CEO Dr Ludovic Labat